Drug Approval | March 09, 2023
Caplin Steriles gets USFDA approval for Thiamine Hydrochloride Injection
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Following successful completion of full set of clinical studies of proposed rituximab biosimilar candidate DRL_RI, Dr. Reddy’s will now prepare to file in the United States, European Union and other regions
The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India
Therapy recently approved in Canada under the brand name KORSUVA
The decision follows authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in May 2022.
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
First launches expected in H1 2022
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
Subscribe To Our Newsletter & Stay Updated
